EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:90199 |
| ChEBI Name | c-Met tyrosine kinase inhibitor |
| Stars | |
| Definition | An EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor that interferes with the action of c-Met tyrosine kinase. |
| Last Modified | 9 September 2024 |
| Submitter | Gareth Owen |
| Wikipedia |
|---|
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| c-Met tyrosine kinase inhibitor (CHEBI:90199) is a EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor (CHEBI:62434) |
| Incoming Relation(s) |
| AMG-208 (CHEBI:90626) has role c-Met tyrosine kinase inhibitor (CHEBI:90199) |
| capmatinib (CHEBI:231693) has role c-Met tyrosine kinase inhibitor (CHEBI:90199) |
| foretinib (CHEBI:91418) has role c-Met tyrosine kinase inhibitor (CHEBI:90199) |
| MK-2461 (CHEBI:230540) has role c-Met tyrosine kinase inhibitor (CHEBI:90199) |
| PHA-665752 (CHEBI:90197) has role c-Met tyrosine kinase inhibitor (CHEBI:90199) |
| savolitinib (CHEBI:231369) has role c-Met tyrosine kinase inhibitor (CHEBI:90199) |
| SGX-523 (CHEBI:90624) has role c-Met tyrosine kinase inhibitor (CHEBI:90199) |
| SU11274 (CHEBI:190974) has role c-Met tyrosine kinase inhibitor (CHEBI:90199) |
| Synonyms | Source |
|---|---|
| MET inhibitors | ChEBI |
| c-Met tyrosine kinase inhibitors | ChEBI |
| c-Met inhibitors | ChEBI |
| MET inhibitor | ChEBI |
| MET proto-oncogene, receptor tyrosine kinase inhibitor | ChEBI |
| MET proto-oncogene, receptor tyrosine kinase inhibitors | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| C-Met_inhibitors | Wikipedia |